BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22305012)

  • 1. Optimal dose of contrast medium for depiction of hypervascular HCC on dynamic MDCT.
    Fujigai T; Kumano S; Okada M; Hyodo T; Imaoka I; Yagyu Y; Ashikaga R; Ishii K; Murakami T
    Eur J Radiol; 2012 Nov; 81(11):2978-83. PubMed ID: 22305012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommended iodine dose for multiphasic contrast-enhanced mutidetector-row computed tomography imaging of liver for assessing hypervascular hepatocellular carcinoma: multicenter prospective study in 77 general hospitals in Japan.
    Ichikawa T; Okada M; Kondo H; Sou H; Murakami T; Kanematsu M; Yoshikawa S; Shiosakai K; Hayakawa A; Awai K; Yoshimitsu K; Yamashita Y
    Acad Radiol; 2013 Sep; 20(9):1130-6. PubMed ID: 23931427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal arterial phase imaging for detection of hypervascular hepatocellular carcinoma determined by continuous image capture on 16-MDCT.
    Ma X; Samir AE; Holalkere NS; Sahani DV
    AJR Am J Roentgenol; 2008 Sep; 191(3):772-7. PubMed ID: 18716108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moderate versus high concentration of contrast material for aortic and hepatic enhancement and tumor-to-liver contrast at multi-detector row CT.
    Awai K; Inoue M; Yagyu Y; Watanabe M; Sano T; Nin S; Koike R; Nishimura Y; Yamashita Y
    Radiology; 2004 Dec; 233(3):682-8. PubMed ID: 15486215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypervascular hepatocellular carcinomas: bolus tracking with a 40-detector CT scanner to time arterial phase imaging.
    Sultana S; Awai K; Nakayama Y; Nakaura T; Liu D; Hatemura M; Funama Y; Morishita S; Yamashita Y
    Radiology; 2007 Apr; 243(1):140-7. PubMed ID: 17329690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of hypervascular hepatocellular carcinoma in cirrhotic liver by means of helical CT: comparison of different contrast medium concentrations within the same patient.
    Sultana S; Morishita S; Awai K; Kawanaka K; Ohyama Y; Nakayama Y; Imuta M; Arakawa A; Yamashita Y
    Radiat Med; 2003; 21(6):239-45. PubMed ID: 14743896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of hypervascular hepatocellular carcinoma in cirrhotic liver: comparison of different concentrations of contrast material with multi-detector row helical CT--a prospective randomized study.
    Sofue K; Tsurusaki M; Kawasaki R; Fujii M; Sugimura K
    Eur J Radiol; 2011 Dec; 80(3):e237-42. PubMed ID: 21067880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal contrast dose for depiction of hypervascular hepatocellular carcinoma at dynamic CT using 64-MDCT.
    Yanaga Y; Awai K; Nakaura T; Namimoto T; Oda S; Funama Y; Yamashita Y
    AJR Am J Roentgenol; 2008 Apr; 190(4):1003-9. PubMed ID: 18356448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal scan timing of hepatic arterial-phase imaging of hypervascular hepatocellular carcinoma determined by multiphasic fast CT imaging technique.
    Kagawa Y; Okada M; Yagyu Y; Kumano S; Kanematsu M; Kudo M; Murakami T
    Acta Radiol; 2013 Oct; 54(8):843-50. PubMed ID: 23761547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing of the hepatic arterial phase at Gd-EOB-DTPA-enhanced hepatic dynamic MRI: comparison of the test-injection and the fixed-time delay method.
    Nakamura S; Nakaura T; Kidoh M; Utsunomiya D; Doi Y; Harada K; Uemura S; Yamashita Y
    J Magn Reson Imaging; 2013 Sep; 38(3):548-54. PubMed ID: 23744782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic contrast-enhanced MDCT of the liver: analysis of the effect of different iodine concentrations with the same total iodine dose in the same chronic liver disease patients.
    Tozaki M; Naruo K; Fukuda K
    Radiat Med; 2005 Dec; 23(8):533-8. PubMed ID: 16555560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal dose and injection duration (injection rate) of contrast material for depiction of hypervascular hepatocellular carcinomas by multidetector CT.
    Yanaga Y; Awai K; Nakayama Y; Nakaura T; Tamura Y; Funama Y; Aoyama M; Asada N; Yamashita Y
    Radiat Med; 2007 Jul; 25(6):278-88. PubMed ID: 17634881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aortic and hepatic enhancement and tumor-to-liver contrast: analysis of the effect of different concentrations of contrast material at multi-detector row helical CT.
    Awai K; Takada K; Onishi H; Hori S
    Radiology; 2002 Sep; 224(3):757-63. PubMed ID: 12202710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can low-dose CT with iterative reconstruction reduce both the radiation dose and the amount of iodine contrast medium in a dynamic CT study of the liver?
    Takahashi H; Okada M; Hyodo T; Hidaka S; Kagawa Y; Matsuki M; Tsurusaki M; Murakami T
    Eur J Radiol; 2014 Apr; 83(4):684-91. PubMed ID: 24418284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depiction of hypervascular hepatocellular carcinoma with 64-MDCT: comparison of moderate- and high-concentration contrast material with and without saline flush.
    Matoba M; Kitadate M; Kondou T; Yokota H; Tonami H
    AJR Am J Roentgenol; 2009 Sep; 193(3):738-44. PubMed ID: 19696287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low contrast dose protocol involving a 100 kVp tube voltage for hypervascular hepatocellular carcinoma in patients with renal dysfunction.
    Nakaura T; Nagayama Y; Kidoh M; Nakamura S; Namimoto T; Awai K; Harada K; Yamashita Y
    Jpn J Radiol; 2015 Sep; 33(9):566-76. PubMed ID: 26162707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High concentration (400 mgI/mL) versus low concentration (320 mgI/mL) iodinated contrast media in multi detector computed tomography of the liver: a randomized, single centre, non-inferiority study.
    Rengo M; Caruso D; De Cecco CN; Lucchesi P; Bellini D; Maceroni MM; Ferrari R; Paolantonio P; Iafrate F; Carbone I; Vecchietti F; Laghi A
    Eur J Radiol; 2012 Nov; 81(11):3096-101. PubMed ID: 22683195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDCT of hypervascular hepatocellular carcinomas: a prospective study using contrast materials with different iodine concentrations.
    Yagyu Y; Awai K; Inoue M; Watai R; Sano T; Hasegawa H; Nishimura Y
    AJR Am J Roentgenol; 2005 May; 184(5):1535-40. PubMed ID: 15855112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimally Required Iodine Dose for the Detection of Hypervascular Hepatocellular Carcinoma on 80-kVp CT.
    Goshima S; Kanematsu M; Noda Y; Kawai N; Kawada H; Ono H; Bae KT
    AJR Am J Roentgenol; 2016 Mar; 206(3):518-25. PubMed ID: 26901007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abdominal multi-detector row CT: effectiveness of determining contrast medium dose on basis of body surface area.
    Onishi H; Murakami T; Kim T; Hori M; Osuga K; Tatsumi M; Higashihara H; Maeda N; Tsuboyama T; Nakamoto A; Tomoda K; Tomiyama N
    Eur J Radiol; 2011 Dec; 80(3):643-7. PubMed ID: 20864283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.